Skip to content

The effect of Dragon's blood cream on localized Eczema

Investigation of Dragon’s blood cream in patients with localized Eczema,a double blind randomized, placebo controlled Clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013102515147N1
Enrollment
70
Registered
2014-03-09
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema. Other atopic dermatitis

Interventions

Intervention 1: 1: Patients In therapeutic group will use therapeutic cream twice a day and will be visited in 7th and 14th days. Intervention 2: 2: Patients in placebo group will use placebo cream t
Treatment - Drugs
Placebo
1: Patients In therapeutic group will use therapeutic cream twice a day and will be visited in 7th and 14th days.
2: Patients in placebo group will use placebo cream twice a day and will be visited in 7th and 14th days.

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 65 Years

Inclusion criteria

Inclusion criteria: (Including criteria: Ages between 7-65 years; Surface of lesion should be less than 5% of body area; (Excluding criteria: Pregnancy after starting clinical trial; Tendency to withdraw from study ; Sensitization to active material or other ingredient of formulation)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Surface, Erythema, Edema, Exuda, Vesicle and Papule, Scaling, Fissure, Itching. Timepoint: 14 days. Method of measurement: According to severity was scored 0 to 3.

Secondary

MeasureTime frame
Quality of life. Timepoint: 14 days. Method of measurement: Questionnaire was filled in days 0 and 14.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Foroogh Namjooyan

Ahvaz Jundishapur University of Medical Sciences

namjooyan.f@ajums.ac.ir namjoyan@yahoo.com+98 61 1373 8380

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026